Genscript Biotech Statistics

Total Valuation

GNNSF has a market cap or net worth of 3.12 billion. The enterprise value is 3.23 billion.

Market Cap	3.12B
Enterprise Value	3.23B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.37%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.36B

Valuation Ratios

The trailing PE ratio is 1.06.

PE Ratio	1.06
Forward PE	n/a
PS Ratio	5.26
PB Ratio	0.72
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	41.31
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 70.26, with an EV/FCF ratio of -26.88.

EV / Earnings	1.09
EV / Sales	5.43
EV / EBITDA	70.26
EV / EBIT	n/a
EV / FCF	-26.88

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.17.

Current Ratio	2.72
Quick Ratio	2.46
Debt / Equity	0.17
Debt / EBITDA	8.51
Debt / FCF	-6.02
Interest Coverage	1.16

Financial Efficiency

Return on equity (ROE) is -5.46% and return on invested capital (ROIC) is 0.15%.

Return on Equity (ROE)	-5.46%
Return on Assets (ROA)	0.13%
Return on Invested Capital (ROIC)	0.15%
Return on Capital Employed (ROCE)	0.19%
Revenue Per Employee	106,768
Profits Per Employee	531,946
Employee Count	5,568
Asset Turnover	0.14
Inventory Turnover	7.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.33% in the last 52 weeks. The beta is 1.03, so GNNSF's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-13.33%
50-Day Moving Average	1.54
200-Day Moving Average	1.44
Relative Strength Index (RSI)	31.18
Average Volume (20 Days)	1,127

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GNNSF had revenue of 594.49 million and earned 2.96 billion in profits. Earnings per share was 1.40.

Revenue	594.49M
Gross Profit	272.13M
Operating Income	9.28M
Pretax Income	-170.80M
Net Income	2.96B
EBITDA	70.04M
EBIT	9.28M
Earnings Per Share (EPS)	1.40

Full Income Statement

Balance Sheet

The company has 621.24 million in cash and 723.74 million in debt, giving a net cash position of -102.50 million.

Cash & Cash Equivalents	621.24M
Total Debt	723.74M
Net Cash	-102.50M
Net Cash Per Share	n/a
Equity (Book Value)	4.32B
Book Value Per Share	2.02
Working Capital	527.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 75.65 million and capital expenditures -195.79 million, giving a free cash flow of -120.14 million.

Operating Cash Flow	75.65M
Capital Expenditures	-195.79M
Free Cash Flow	-120.14M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 45.77%, with operating and profit margins of 1.56% and 498.22%.

Gross Margin	45.77%
Operating Margin	1.56%
Pretax Margin	-28.73%
Profit Margin	498.22%
EBITDA Margin	11.78%
EBIT Margin	1.56%
FCF Margin	n/a

Dividends & Yields

GNNSF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.37%
Shareholder Yield	-3.37%
Earnings Yield	94.78%
FCF Yield	-3.84%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GNNSF has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a